The current earnings forecast score of HeartSciences Inc is 8.00, ranking 67 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 13.50, with a high of 15.00 and a low of 12.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
10.000
Target Price
+258.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
HeartSciences Inc
HSCS
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is HeartSciences Inc's price target?
Analysts forecast that HeartSciences Inc's price target is USD 13.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 12.00.
How have HeartSciences IncHSCS's recent earnings per share performed?
The market expectation was USD -0.63, while HeartSciences IncHSCS's earnings per share (EPS) for the previous quarter was USD -0.85. EPS for the next quarter is expected at USD -0.73.
What is the analyst rating for HeartSciences Inc?
Based on the ratings of HeartSciences Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.